Envista Holdings Co. (NYSE:NVST) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D lessened its stake in shares of Envista Holdings Co. (NYSE:NVST) by 3.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 103,611 shares of the company’s stock after selling 4,075 shares during the period. State of New Jersey Common Pension Fund D owned 0.06% of Envista worth $1,999,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. Creative Planning raised its holdings in Envista by 30.2% in the 3rd quarter. Creative Planning now owns 31,575 shares of the company’s stock valued at $624,000 after acquiring an additional 7,329 shares during the last quarter. Blue Trust Inc. raised its holdings in Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Envista in the 3rd quarter valued at about $31,000. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in Envista by 11.2% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 15,314 shares of the company’s stock valued at $303,000 after acquiring an additional 1,538 shares during the last quarter.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on NVST. Robert W. Baird raised their price target on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Jefferies Financial Group raised their price target on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Piper Sandler raised their price target on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday, February 3rd. Leerink Partnrs raised shares of Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Finally, Wells Fargo & Company increased their price objective on shares of Envista from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 6th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $20.21.

Envista Trading Down 2.5 %

NYSE NVST opened at $20.91 on Monday. Envista Holdings Co. has a one year low of $15.15 and a one year high of $23.06. The company has a 50-day simple moving average of $20.11 and a 200-day simple moving average of $19.55. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. The firm has a market capitalization of $3.60 billion, a PE ratio of -3.22, a price-to-earnings-growth ratio of 1.27 and a beta of 1.34.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.